Virtu KCG Holdings’s West Pharmaceutical WST Stock Holding History

Virtu KCG Holdings’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$711K	Buy	7,518 +3,025	+67%	+$278K	0.02%	834
2017 Q1	$367K	Sell	4,493 -1,251	-22%	-$105K	0.01%	1718
2016 Q4	$487K	Sell	5,744 -2,724	-32%	-$214K	0.01%	1529
2016 Q3	$631K	Buy	+8,468	New	+$672K	0.02%	1155
2016 Q1	–	Sell	-14,767	Closed	-$889K	–	3749
2015 Q4	$889K	Sell	14,767 -3,915	-21%	-$236K	0.02%	968
2015 Q3	$1.01M	Buy	+18,682	New	+$1.09M	0.02%	882
2014 Q3	–	Sell	-4,858	Closed	-$205K	–	4117
2014 Q2	$205K	Sell	4,858 -4,681	-49%	-$200K	﹤0.01%	3048
2014 Q1	$420K	Buy	9,539 +2,730	+40%	+$129K	0.01%	2155
2013 Q4	$334K	Buy	+6,809	New	+$319K	﹤0.01%	2448

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Virtu KCG Holdings's WST Position: Q2 2017 in Review

Virtu KCG Holdings increased its West Pharmaceutical (WST) stake by 67% in Q2 2017, buying an estimated $278K and bringing the position to 7,518 shares worth $711K. The position accounts for 0.02% of the portfolio, ranked #834.

Virtu KCG Holdings first reported a position in WST in Q4 2013 and has held it in 9 quarters since. The position peaked at $1.01M in Q3 2015. 310 funds tracked by Wall St. Rank hold WST as of Q2 2017.

Virtu KCG Holdings held 7,518 shares of West Pharmaceutical worth $711K as of Q2 2017.
Virtu KCG Holdings bought 3,025 West Pharmaceutical shares in Q2 2017, an estimated $278K.
West Pharmaceutical made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #834 holding.
Virtu KCG Holdings first reported a position in West Pharmaceutical in Q4 2013 and has held it in 9 quarters since.
Virtu KCG Holdings's West Pharmaceutical position peaked at $1.01M in Q3 2015.
310 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.